← Russell 3000 cross-section

HIMS Hims & Hers Health, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-10, not restated
Healthcare

Scale

Market cap
$7.4bn
Revenue TTM
$2.6bn
Net income TTM
$-142m
Free cash flow
$62m
Composite score
49.9
Sector rank
#860

Valuation

P / E
EV / EBITDA
EV / sales
2.5
FCF yield
0.83%
Earnings yield vs 10-yr
-6.65pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-5.5%
EBITDA margin
-2.6%
ROE
-43.8%
ROIC
Revenue growth
28.0%

Insider activity, last 90 days

Net open-market
$-7.21m
Buyers
0
Sellers
7

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Our management primarily uses the Subscribers and Monthly Revenue per Average Subscriber metric, each as defined below, to manage and monitor the performance of our business. Our consolidated revenue primarily comprises online sales of health and wellness products through our websites and mobile applications, including prescription and non-prescription products, as well as services, primarily consisting of medical consultation services, membership-based access, post-consultation service support, and delivery of laboratory testing results, as applicable. GAAP, primarily relating to deferred revenue and returns reserve. …Hims & Hers Health, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-10

Read the full passage →